These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 2835397

  • 1. Dual mechanisms of regulation of type I iodothyronine 5'-deiodinase in the rat kidney, liver, and thyroid gland. Implications for the treatment of hyperthyroidism with radiographic contrast agents.
    St Germain DL.
    J Clin Invest; 1988 May; 81(5):1476-84. PubMed ID: 2835397
    [Abstract] [Full Text] [Related]

  • 2. Ligand-induced inactivation of type I iodothyronine 5'-deiodinase: protection by propylthiouracil in vivo and reversibility in vitro.
    St Germain DL, Croteau W.
    Endocrinology; 1989 Nov; 125(5):2735-44. PubMed ID: 2792006
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Retinoids stimulate type I iodothyronine 5'-deiodinase activity in human follicular thyroid carcinoma cell lines.
    Schreck R, Schnieders F, Schmutzler C, Köhrle J.
    J Clin Endocrinol Metab; 1994 Sep; 79(3):791-8. PubMed ID: 8077363
    [Abstract] [Full Text] [Related]

  • 5. Pretranslational regulation of type I 5'-deiodinase by thyroid hormones and in fasted and diabetic rats.
    O'Mara BA, Dittrich W, Lauterio TJ, St Germain DL.
    Endocrinology; 1993 Oct; 133(4):1715-23. PubMed ID: 8404614
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Proinflammatory cytokines inhibit the expression and function of human type I 5'-deiodinase in HepG2 hepatocarcinoma cells.
    Jakobs TC, Mentrup B, Schmutzler C, Dreher I, Köhrle J.
    Eur J Endocrinol; 2002 Apr; 146(4):559-66. PubMed ID: 11916626
    [Abstract] [Full Text] [Related]

  • 8. In vivo effects of macrolides on thyroid hormone serum levels and on hepatic type 1 5'-deiodinase in rat. A comparative study with amiodarone, phenobarbital and propranolol.
    Perret G, Yin YL, Nicolas P, Vassy R, Uzzan B, Louchahi M.
    Fundam Clin Pharmacol; 1991 Apr; 5(7):583-93. PubMed ID: 1778536
    [Abstract] [Full Text] [Related]

  • 9. 3,5-diiodo-L-thyronine stimulates type 1 5'deiodinase activity in rat anterior pituitaries in vivo and in reaggregate cultures and GH3 cells in vitro.
    Baur A, Bauer K, Jarry H, Köhrle J.
    Endocrinology; 1997 Aug; 138(8):3242-8. PubMed ID: 9231774
    [Abstract] [Full Text] [Related]

  • 10. Physiological and genetic analyses of inbred mouse strains with a type I iodothyronine 5' deiodinase deficiency.
    Berry MJ, Grieco D, Taylor BA, Maia AL, Kieffer JD, Beamer W, Glover E, Poland A, Larsen PR.
    J Clin Invest; 1993 Sep; 92(3):1517-28. PubMed ID: 8104199
    [Abstract] [Full Text] [Related]

  • 11. Iodothyronine deiodinase activities in FRTL5 cells: predominance of type I 5'-deiodinase.
    Borges M, Ingbar SH, Silva JE.
    Endocrinology; 1990 Jun; 126(6):3059-68. PubMed ID: 2351108
    [Abstract] [Full Text] [Related]

  • 12. The type I iodothyronine 5'-deiodinase messenger ribonucleic acid is localized to the S3 segment of the rat kidney proximal tubule.
    Lee WS, Berry MJ, Hediger MA, Larsen PR.
    Endocrinology; 1993 May; 132(5):2136-40. PubMed ID: 8477661
    [Abstract] [Full Text] [Related]

  • 13. Antithyroid effects of naringin, hesperidin and rutin in l-T4 induced hyperthyroid rats: possible mediation through 5'DI activity.
    Panda S, Kar A.
    Pharmacol Rep; 2014 Dec; 66(6):1092-9. PubMed ID: 25443740
    [Abstract] [Full Text] [Related]

  • 14. Differential selenium-dependent expression of type I 5'-deiodinase and glutathione peroxidase in the porcine epithelial kidney cell line LLC-PK1.
    Gross M, Oertel M, Köhrle J.
    Biochem J; 1995 Mar 15; 306 ( Pt 3)(Pt 3):851-6. PubMed ID: 7702583
    [Abstract] [Full Text] [Related]

  • 15. Type I 5'-iodothyronine deiodinase activity and mRNA are remarkably reduced in renal clear cell carcinoma.
    Pachucki J, Ambroziak M, Tanski Z, Luczak J, Nauman J, Nauman A.
    J Endocrinol Invest; 2001 Apr 15; 24(4):253-61. PubMed ID: 11383912
    [Abstract] [Full Text] [Related]

  • 16. Conversion of thyroxine to triiodothyronine in the anterior pituitary gland and the influence of this process on thyroid status.
    Kaplan MM, Breitbart R.
    Horm Metab Res Suppl; 1984 Apr 15; 14():79-85. PubMed ID: 6595194
    [Abstract] [Full Text] [Related]

  • 17. Influence of pharmacological doses of iopanoic acid and thyroxine 5- and 5'-monodeiodination in liver and kidney of the pig.
    Slebodziński AB, Brzezińska-Slebodzinska E, Dudzińska J.
    Exp Clin Endocrinol; 1986 Jun 15; 87(1):63-8. PubMed ID: 3743648
    [Abstract] [Full Text] [Related]

  • 18. Photoaffinity labeling of rat type I iodothyronine deiodinase.
    Kieffer JD, Larsen PR.
    Endocrinology; 1991 Aug 15; 129(2):1042-8. PubMed ID: 1855452
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of 5'DI and 5'DII L-tiroxine (T4) monodeiodinases. Effect on the hypothalamo-pituitary ovarian axis in adult hypothyroid rats treated with T4.
    Ortega E, Osorio A, Ruiz E.
    Biochem Mol Biol Int; 1996 Jul 15; 39(4):853-60. PubMed ID: 8843355
    [Abstract] [Full Text] [Related]

  • 20. Defective stimulation of thyroxine 5'-deiodinase activity by cold exposure and norepinephrine in brown adipose tissue of monosodium glutamate-obese mice.
    Tsukahara F, Uchida Y, Ohba K, Nomoto T, Muraki T.
    Horm Metab Res; 1997 Oct 15; 29(10):496-500. PubMed ID: 9405975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.